Auditdata has added the NAL-NL3 hearing aid prescription and Oldenburg Matrix Sentence Test to its Measure™ software , combining two complementary tools for hearing aid fitting and outcome assessment into one platform. Announced October 7, both additions are available in Measure release 6.6.0....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists using Auditdata Measure™ can now access NAL-NL3 targets and the Oldenburg Matrix Sentence Test directly in the platform from release 6.6.0; those already using NAL-NL2 and a separate speech-in-noise test may consider evaluating whether consolidating into Measure streamlines their workflow, but no change to clinical best-practice targets is required.
Integration of the first major NAL prescription update in 15 years into a commercial fitting platform lowers the barrier for clinics to adopt evidence-based, machine-learning-informed targets at scale.
- 01NAL-NL3 is the first new National Acoustic Laboratories prescription formula in 15 years, succeeding NAL-NL2.
- 02NAL-NL3 uses a modular, machine-learning-powered approach to deliver more personalised hearing aid targets.
- 03The Oldenburg Matrix Sentence Test — a validated speech-in-noise assessment — is also newly integrated.
- 04Features are available in Measure™ release 6.6.0; additional NAL-NL3 modules (Comfort in Noise, Minimal Hearing Loss) follow in v6.7.0.
- 05This is a software platform update announcement, not a clinical trial; no outcome data are presented.
NAL-NL3 is the first new National Acoustic Laboratories prescription formula in 15 years.
press releasepartially supportedNAL-NL3 delivers more personalised, evidence-based fittings tailored to each patient's specific listening needs compared to NAL-NL2.
press releasepromotionalNAL-NL3 uses a modular, machine-learning-powered architecture.
press releasepartially supported